Health Care · Laboratory Analytical Instruments · NYSE · CIK 1037646 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $1,395.25 · Day +0.14% · Mkt cap $28.0B · P/E (FY) 33.2× · 1Y +9.2% · Off 52W high −8.5% · Vol (1Y) 32.1% Price2023-08-21 → 2026-08-21 MTD close: $1,170 on 2023-08-21 to $1,395 on 2026-08-21. Split-adj closes · 240 of 5,313 · price returnⓘ At a glance | Short interest3.9% of sh out | | Days to cover4.2d | | 13F net flow (QoQ)−2.82% | | Top-10 13F concentration47.8% | | Next report (est.)2026-10-29 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)33.2× | | Sales (TTM)$4.13B | | Earnings (TTM)$905.6M | | Net margin21.6% | | EPS growth 3Y3.1% | | Sales growth 3Y0.9% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+0.1% | | 1Y+9.2% | | 3Y+19.3% | | 5Y−8.9% | | 10Y+241.4% | | Since incept. (ann.)+17.4% |
Total return · from 2005-07-07ⓘ Risk | Ann. volatility (1Y)32.1% | | Ann. volatility (3Y)32.9% | | Sharpe (1Y)0.34 | | Sharpe (3Y)0.34 | | Max drawdown (1Y)−31.9% | | Max drawdown (3Y)−36.6% | | Beta (3Y vs SPY)1.04 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 1.8M | $2.2B | 8.76% | +1.9% | | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $1.7B | 6.54% | new | | Capital International Investors | 1.1M | $1.4B | 5.35% | +11.5% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 996,084 | $1.3B | 4.93% | new | | STATE STREET CORP | 942,535 | $1.2B | 4.66% | +0.3% | | ALLIANCEBERNSTEIN L.P. | 757,108 | $1.1B | 3.75% | −4.7% | | T. Rowe Price Investment Management, Inc. | 732,053 | $923M | 3.62% | −36.1% | | Bank of New York Mellon Corp | 703,479 | $887M | 3.48% | −4.4% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-07-30 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-07-30 | $11.55 | +18.3% | $1.03B | +4.5% | | 2026-03-31 | 2026-05-07 | $8.33 | +6.7% | $947.1M | +7.2% | | 2025-12-31 | 2026-02-05 | $13.91 | +16.8% | $1.13B | +8.1% | | 2025-09-30 | 2025-11-06 | $10.57 | +6.1% | $1.03B | +7.9% |
As-reported XBRL · next 2026-10-29 est.ⓘ Segment mixFY2025 (ended Dec 2025) USOperations 37% · Western European Operations 22% · Other Operations 20% · Chinese Operations 16% · Swiss Operations 5% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
